Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jazz Pharma Plc (NQ: JAZZ ) 114.29 +0.42 (+0.37%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jazz Pharma Plc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal August 23, 2024 Via Benzinga A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals August 19, 2024 Via Benzinga In a market where value is scarce, NASDAQ:JAZZ offers a refreshing opportunity with its solid fundamentals. August 08, 2024 Don't overlook JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ)—it's a hidden gem with strong fundamentals and an attractive price tag. Via Chartmill The 3 Best Cannabis Stocks to Buy in August 2024 August 05, 2024 Although cannabis stocks have been brutalized earlier, favorable legal winds could make the sector intriguing again. Via InvestorPlace Topics Cannabis Exposures Cannabis Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals August 01, 2024 Via Benzinga 3 Biotech Stocks to Buy on the Dip: July 2024 July 29, 2024 Biotech stocks are critically important to the broader market. However, it might make more sense to consider buying on the dip. Via InvestorPlace How Is The Market Feeling About Jazz Pharmaceuticals? July 15, 2024 Via Benzinga Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts July 02, 2024 Via Benzinga Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals June 05, 2024 Via Benzinga Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails July 24, 2024 The companies are no longer developing their drug for essential tremor treatment. Via Investor's Business Daily If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names July 19, 2024 Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July. Via InvestorPlace Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US July 11, 2024 The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical... Via Benzinga Topics Cannabis Exposures Cannabis Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country July 11, 2024 Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company... Via Benzinga Topics Cannabis Exposures Cannabis Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews May 02, 2024 Via Benzinga 3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential July 04, 2024 Large cap stocks are where the alpha is now, but there’s a case to be made for these undervalued mid-cap growth stocks Via InvestorPlace 7 Biotech Stocks to Boost Your Portfolio to Peak Health June 26, 2024 With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. Via InvestorPlace 3 Cannabis Stocks That Could Make Your Grandchildren Rich June 25, 2024 These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today. Via InvestorPlace Topics Cannabis Exposures Cannabis Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday? June 20, 2024 Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo. Via Benzinga Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure June 20, 2024 The companies are working on treatments for essential tremor, a tricky indication. Via Investor's Business Daily 3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition June 14, 2024 These blue-chip stocks offer stability, sustainable growth and operational models less prone to wider economic fluctuations. Via InvestorPlace This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday June 05, 2024 Via Benzinga 7 Overlooked Stocks Offering Long-Term Stability From the Shadows June 03, 2024 These overlooked stocks offer price appreciation, income, and more while diversifying across sectors and company sizes. Via InvestorPlace 3 Cannabis Stocks to Buy Now: May 2024 May 26, 2024 These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives. Via InvestorPlace Topics Cannabis Exposures Cannabis 7 Blue-Chip Stocks to Buy Now: May 2024 May 23, 2024 These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability. Via InvestorPlace Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch May 18, 2024 President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). Via Benzinga Topics Cannabis Exposures Cannabis 3 Cheap Blue-Chip Stocks to Buy Now: May 2024 May 17, 2024 If stock market speculation isn't quite working in your favor, these cheap blue-chip stocks may be the boost your portfolio needs. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session May 15, 2024 Via Benzinga Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In May 14, 2024 Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. Via Benzinga Topics Cannabis Exposures Cannabis 7 Cannabis Stocks to Buy for a Smoking-Hot 2024 May 09, 2024 Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts. Via InvestorPlace Topics Cannabis Exposures Cannabis The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? May 08, 2024 These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes. Via InvestorPlace Topics Cannabis Exposures Cannabis < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.